跳到正文
原文
Nature 健康护理主题·· 24 天前AI 评分48

伊朗全国调查显示94.26%成年人处于CKM综合征1–4期,2期占65.73%

Patterns of cardiovascular-kidney-metabolic (CKM) syndrome stages and prevalence of lifestyle risk factors in a nationally representative iranian population study

AI 导读

基于2021年STEPS调查16,208名25岁以上伊朗成年人的二次分析,94.26%符合CKM综合征1–4期标准,其中2期占比最高(65.73%),1期为13.08%。高血压和代谢综合征是最常见的心血管代谢疾病,3期和4期参与者中分别有63.83%和57.89%报告至少两项不健康生活方式因素,果蔬摄入不足在各期均最常见。作者表示,该横断面分析提供的是全国及地区分期分布的描述性证据。

正文

Scientific Reports (2026) Cite this article

We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.

Abstract

Cardiovascular-kidney-metabolic (CKM) syndrome contributes substantially to mortality and places a substantial burden on healthcare systems. Despite the high prevalence of cardiac, renal, and metabolic disorders in Iran, nationally representative data describing the CKM stage distribution and associated unhealthy lifestyle factors are lacking. We aimed to investigate the national pattern of CKM stages and the prevalence of unhealthy lifestyle behaviors among Iranian adults. This secondary analysis used data from the 2021 STEPS survey. Sociodemographic characteristics, lifestyle factors, and renal, metabolic, and cardiovascular risk indicators were presented across CKM stages (0–4). Geographical variations in stage distribution were also assessed. Categorical variables were presented as weighted percentages with corresponding 95% confidence intervals (CIs). A total of 16,208 participants aged ≥ 25 years were analyzed. Overall, 94.26% of participants met the criteria for CKM stages 1–4, with stage 2 accounting for the largest proportion (65.73%, 95% CI: 64.68, 66.78), followed by stage 1 (13.08%, 95% CI: 12.35, 13.82). Hypertension and metabolic syndrome were the most prevalent cardiometabolic conditions, whereas moderate- to high-risk and very high-risk CKD were the least prevalent. Geographic variations were observed, with northwestern and southwestern provinces showing high stage 3 prevalence but relatively low stage 4 prevalence. Overall, 63.83% (95% CI: 59.74, 67.92) of participants in stage 3 and 57.89% (95% CI: 54.20, 61.58) in stage 4 reported at least two unhealthy lifestyle factors, while 10.19% (95% CI: 7.77, 12.61) and 11.85% (95% CI: 8.98, 14.72), respectively, reported three or more factors. Insufficient fruit and vegetable intake was the most prevalent unhealthy lifestyle factor across all CKM stages. CKM syndrome affects most Iranian adults, predominantly at stage 2. These findings provide descriptive evidence of the national and regional distribution of CKM stages.

Abbreviations

CKM:

Cardiovascular-kidney-metabolic

AHA:

The American Heart Association

CKD:

Chronic kidney disease

CVD:

Cardiovascular diseases

BMI:

Body mass index

STEPS:

STEPwise approach to non-communicable disease

WHO:

The world health organization

NCD:

Non-communicable disease

STROBE:

The strengthening the reporting of observational studies in epidemiology

PCA:

Principal component analysis

GPAQ-v2:

Global physical activity questionnaire

MET:

Metabolic equivalent of task

WC:

Waist circumference

HDL-C:

High-density lipoprotein-cholesterol

TC:

Total cholesterol

TG:

Triglycerides

FBS:

Fasting blood glucose

HbA1C:

Hemoglobin A1c

LDL-C:

Low-density lipoprotein-cholesterol

eGFR:

Estimated glomerular filtration rate

PREVENT:

Predicting risk of cardiovascular disease EVENTs

DM:

Diabetes mellitus

SBP:

Systolic blood pressure

DBP:

Diastolic blood pressure

KDIGO:

The kidney disease improving global outcomes

CIs:

Confidence intervals

UI:

Uncertainty interval

DALYs:

Disability-adjusted life years

WHO-PEN:

The WHO package of essential non-communicable diseases

JACC:

The journal of the American college of cardiology

DASH:

The dietary approaches to stop hypertension

ASCVD:

Atherosclerotic cardiovascular disease

Acknowledgements

This research was supported by the National Institute of Health Research of the Islamic Republic of Iran and the Tehran University of Medical Sciences. We would like to express our sincere appreciation to all colleagues at the Non‑Communicable Diseases Research Center (NCDRC), Diabetes Research Center, and the Endocrinology and Metabolism Research Institute (EMRI) of Tehran University of Medical Sciences for their invaluable support and collaboration throughout this study.

Funding

This work was undertaken as part of the larger project titled “Personalized Medicine Applications in Clinical Practice in Iran: A New Strategy for Improving Public Health”. It was supported by grants awarded to Dr Mohammad Reza Amini from the following research centres at the Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran: the Non-Communicable Diseases Research Center, the Personalized Medicine Research Center, and the Diabetes Research Center. Additional support was provided by the Vice-Presidency for Science, Technology and Knowledge-Based Economy Affairs, Islamic Republic of Iran [Grant No. 90680].

Author information

Author notes

  1. Hosein Ataei-Goujani and Mina Mirzad contributed equally to this work: Hosein Ataei-Goujani and Mina Mirzad. Yosra Azizpour and Mandana Hasanzad contributed equally as corresponding authors.

Authors and Affiliations

  1. Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

    Hosein Ataei-Goujani, Mina Mirzad & Yosra Azizpour

  2. Student Research Committee, Shahrekord University of Medical Sciences, Shahrekord, Iran

    Hosein Ataei-Goujani

  3. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

    Mina Mirzad & Bagher Larijani

  4. Diabetes Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

    Mohammad Reza Amini

  5. Personalized Medicine Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

    Mandana Hasanzad

  6. Medical Genomic Research Center, TeMS.C., Islamic Azad University, Tehran, Iran

    Mandana Hasanzad

Authors

  1. Hosein Ataei-Goujani
  2. Mina Mirzad
  3. Mohammad Reza Amini
  4. Yosra Azizpour
  5. Mandana Hasanzad
  6. Bagher Larijani

Corresponding authors

Correspondence to Yosra Azizpour or Mandana Hasanzad.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethical considerations

The current study involved human participants that were reviewed and approved by the Ethical Committee of the National Institute of Health Research (NIHR), Tehran University of Medical Sciences, Tehran, Iran (ID: IR.TUMS.EMRI.REC.1404.034). Moreover, the study was conducted in accordance with the principles outlined in the Declaration of Helsinki. Furthermore, the patients/participants granted their written informed consent to engage in this study. The study results were reported according to the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ataei-Goujani, H., Mirzad, M., Amini, M.R. et al. Patterns of cardiovascular-kidney-metabolic (CKM) syndrome stages and prevalence of lifestyle risk factors in a nationally representative iranian population study. Sci Rep (2026). https://doi.org/10.1038/s41598-026-76826-w

Download citation

  • Received: 06 April 2026

  • Accepted: 15 October 2026

  • Published: 27 October 2026

  • DOI: https://doi.org/10.1038/s41598-026-76826-w

Keywords

来源:Nature 健康护理主题 · nature.com